Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye

CAKALOGLU, YILMAZ

doi:10.14744/hf.2022.2022.0045

Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye

Yılmaz ÇAKAOĞLU (Gastroenteroloji ve Hepatoloji Bölümü, VKV Amerikan Hastanesi, İstanbul, Türkiye)

Hepatology forum

2 0

Yıl: 2023 Cilt: 4 Sayı: 1 Sayfa Aralığı: 40 - 46 Metin Dili: İngilizce DOI: 10.14744/hf.2022.2022.0045 İndeks Tarihi: 04-06-2023

Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye

Öz:

The World Health Organization 2018 report stated that 2.3 billion persons over 15 years old consume alcohol, and a total of 3.0–3.3 million people died because of uncontrolled or harmful alcohol intake in 2016. Injuries, accidents, liver cirrhosis, and other medical disorders are mainly responsible for alco - hol-related disability and deaths. After emphasizing the importance of alco - hol-related disorders and necessary universal precautions, we focus on alcohol consumption features and alcohol-related cirrhosis and hepatocellular carci - noma in Turkiye. It is estimated that alcohol per se is responsible for 12% of cirrhosis and 10% of hepatocellular carcinoma cases. Additional factors such as hepatitis B virus and hepatitis C virus infections have markedly increased the risk of the development of hepatocellular carcinoma in alcoholic cirrhosis.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Global Status Reprot on Alcohol and Health 2018 (Execytive Summary). Geneva, WHO; 2018 (WHO/MSD/MSB/18.2). Licence: CC BY-NC-SA 3.0IGO.
2. GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2018;392(10152):1015-1035.
3. The SAFER; A World free from alcohol related harms. Five areas of inter- vention et national and international levels. Geneva, WHO 2019, Licence: CC BY-NC-SA 3.0IGO.
4. Molina PE, Nelson S. Binge drinking’s effects on the body. Alcohol Res 2018;39(1):99-109.
5. Ventura-Cots M, Ballester-Ferré MP, Ravi S, Bataller R. Public health policies and alcohol-related liver disease. JHEP Rep 2019;1(5):403-413. [CrossRef]
6. Thompson W, Gregory Lande R, Kalapatapu RK. What are the DSM-5 cri- teria for Alcohol Use Disorders. Medscape https://www.medscape.com/an- swers/285913-41535/what-are-the-dsm-5-criteria-for-%20alcohol-use-dis- order Accessed on Nov 27, 2018.
7. Rehm J, Shield KD. Global burden of alcohol use disorders and alcohol liver disease. Biomedicines 2019;7(4):99. [CrossRef]
8. Serfaty L. Clinical implications of concomitant alcohol use, obesity, and viral hepatitis. Gastroenterology 2016;150(8):1718-1722. [CrossRef]
9. Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open 2020;3(4):e201997.
10. Williams R, Aspinall R, Bellis M, Camps-Walsh G, Cramp M, Dhawan A, et al. Addressing liver disease in the UK: a blueprint for attaining ex- cellence in health care and reducing premature mortality from lifestyle is- sues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 2014;384(9958):1953-1997. [CrossRef]
11. Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 2020;5(2):167-228.
12. US Burden of Disease Collaborators, Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, et al. The State of US Health, 1990-2016: Burden of diseas- es, injuries, and risk factors among US states. JAMA 2018;319(14):1444-1472.
13. Stein E, Cruz-Lemini M, Altamirano J, Ndugga N, Couper D, Abraldes JG, Bataller R. Heavy daily alcohol intake at the populatio n level pre- dicts the weight of alcohol in cirrhosis burden worldwid e. J Hep atol 2016;65(5):998-1005. [CrossRef]
14. T.C.Sağlık Bakanlığı, Sağlık İstatistikleri Yıllığı 2018:61-62. [Turkish]
15. T.C. İçişleri Bakanlığı, Emniyet Genel Müdürülüğü Narkotik Suçlarla Mü- cadele Dairesi Başkanlığı. EGM Yayın Katalog 2019;703:91-98. [Turkish]
16. Ökten A. Türkiye’de kronik hepatit, siroz ve hepatosellüler karsinom etiyo- lojisi. Güncel Gastroenteroloji 2003;7(3):187-191. [Turkish]
17. Bayan K, Yilmaz S, Tuzun Y, Yildirim Y. Epidemiological and clinical aspects of liver cirrhosis inadult patients living in Southeastern Anatolia: leading role of HBV in 505 cases. Hepatogastroenterology 2007;54(80):2198-2202.
18. Başyiğit S, Asiltürk Z, Sapmaz F, Kefeli A,Yeniova AÖ, Uzman M, et al. Hepatitis B virüs is still the most common etiologic factor of cirrhosis: Results from a single center in Türkiye. Dicle Med J 2015;42:416-421. [CrossRef]
19. Başsüllü N, Türkmen I, Yaprak O, Dayangaç M, Demirbaş T, Güler N, et al. General evaluation of hepatectomy and hepatocellular carcinoma cases. Turk Patoloji Derg 2011;27(3):221-229. [CrossRef]
20. Çelik F, Tekin F, Ünal NG, Özütemiz Ö. Retrospective analyses of 225 pa- tients with liver cirrhosis: A single center experience. Akademik Gastroen- teroloji Dergisi 2017;16(2)47-53. [Turkish]
21. Idilman R, Aydogan M, Oruncu MB, Kartal A, Elhan AH, Ellik Z, et al. Natural history of cirrhosis: Changing trends in etiology over the years. Dig Dis 2021;39(4):358-365. [CrossRef]
22. Topdagi O, Okcu N, Bilen N. The frequency of complications and the eti- ology of disease in patients with liver cirrhosis in Erzurum. Eurasian J Med 2014;46(2):110-114. [CrossRef]
23. Yıldırım AE, Ucbilek E, Oruncu MB, Turan İ, Demir M, Koksal AS et al. AASLD TASL Digital Hepatology Connect Meeting, Abstract Book, 2021: 17-18, İstanbul.
24. Uzunalimoğlu O, Yurdaydin C, Cetinkaya H, Bozkaya H, Sahin T, Colakoğ-lu S, et al. Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci 2001;46(5):1022-1028. [CrossRef]
25. Ozer B, Serin E, Yilmaz U, Gümürdülü Y, Saygili OB, Kayaselçuk F, et al. Clinicopathologic features and risk factors for hepatocellular carcino- ma: results from a single center in southern Turkey. Turk J Gastroenterol 2003;14(2):85-90.
26. Alacacioglu A, Somali I, Simsek I, Astarcioglu I, Ozkan M, Camci C, et al. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study. Jpn J Clin Oncol 2008;38(10):683-688. [CrossRef]
27. Dogan E, Yalcin S, Koca D, Olmez A. Clinicopathological characteris- tic of hepatocellular carcinoma in Türkiye. Asian Pacivic J Cancer Prev 2012;13(6):2985-2990. [CrossRef]
28. Can A, Dogan E, Bayoglu IV, Tatli AM, Besiroglu M, Kocer M, et al. Mul- ticenter epidemiologic study on hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev 2014;15(6):2923-2927. [CrossRef]
29. Akkiz H, Carr BI, Yalçın KK, Guerra V, Kuran S, Altıntaş E, et al. Char- acteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients. Oncology 2018;94(2):116-124. [CrossRef]
30. Ekinci O, Baran B, Ormeci AC, Soyer OM, Gokturk S, Evirgen S, et al. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma. World J Hepatol 2018;10(1):51-61. [CrossRef]
31. Guzelbulut F, Karaogullarindan U, Akkiz H, Altintas E, Demirtas CO, Ba- hadir O, et al. Characteristics of patients with hepatocellular carcinoma: A multicenter study. Hepatol Forum 2022;3(3):71-76. [CrossRef]
32. Demirtas CO, Gunduz F, Kani HT, Keklikkiran C, Alahdab YO, Yilmaz Y, et al. External validation of the Toronto hepatocellular carcinoma risk index in Turkish cirrhotic patients. Eur J Gastroenterol Hepatol 2020;32(7):882- 888. [CrossRef]
33. Yapalı S, Tozun N. Epidemiology and risk factors for hepatocellulary carcinoma in the Eastern Mediterranean countries. Hepatoma Research, 2018;4:24. [CrossRef]
34. Yankol Y, Mecit N, Kanmaz T, Cimsit B, Cakaloglu Y, Acarli K, et al. Les- sons learned from review of a single center experience with 500 consecutive liver transplants in a region with insufficient deceased-donor support. Exp Clin Transplant 2016;14(2):191-200.
35. European Association for the Study of the Liver. Electronic address: easlof- fice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol 2018;69(1):154-181.
36. Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liv- er disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015;148(3):547-555. [CrossRef]
37. Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2020;71(1):306-333. [CrossRef]
38. Bellentani S, Tiribelli C. The spectrum of liver disease in the general popula- tion: lesson from the Dionysos study. J Hepatol 2001;35(4):531-537.[CrossRef]
39. Tekin F, Gunsar F, Erdogan EI, Sertoz RY, Karasu Z, Ersoz G, et al. Se- roprevalence of hepatitis A, B, and C viruses in Turkish alcoholic cirrhot- ics and the impact of hepatitis B on clinical profile. J Infect Dev Ctries 2015;9(3):254-258. [CrossRef]
40. Vatansever S, Pakoz ZB, Unsal B. Evaluation of hepatitis A, B, and C serol- ogy in patients with cirrhosis and intensive alcohol consumption. North Clin Istanb 2018;5(2):109-113. [CrossRef]
41. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Tur- key: a fieldwork TURHEP study. Clin Microbiol Infect 2015;21(11):1020- 1026. [CrossRef],

APA	CAKALOGLU Y (2023). Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. , 40 - 46. 10.14744/hf.2022.2022.0045
Chicago	CAKALOGLU YILMAZ Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. (2023): 40 - 46. 10.14744/hf.2022.2022.0045
MLA	CAKALOGLU YILMAZ Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. , 2023, ss.40 - 46. 10.14744/hf.2022.2022.0045
AMA	CAKALOGLU Y Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. . 2023; 40 - 46. 10.14744/hf.2022.2022.0045
Vancouver	CAKALOGLU Y Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. . 2023; 40 - 46. 10.14744/hf.2022.2022.0045
IEEE	CAKALOGLU Y "Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye." , ss.40 - 46, 2023. 10.14744/hf.2022.2022.0045
ISNAD	CAKALOGLU, YILMAZ. "Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye". (2023), 40-46. https://doi.org/10.14744/hf.2022.2022.0045

APA	CAKALOGLU Y (2023). Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. Hepatology forum, 4(1), 40 - 46. 10.14744/hf.2022.2022.0045
Chicago	CAKALOGLU YILMAZ Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. Hepatology forum 4, no.1 (2023): 40 - 46. 10.14744/hf.2022.2022.0045
MLA	CAKALOGLU YILMAZ Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. Hepatology forum, vol.4, no.1, 2023, ss.40 - 46. 10.14744/hf.2022.2022.0045
AMA	CAKALOGLU Y Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. Hepatology forum. 2023; 4(1): 40 - 46. 10.14744/hf.2022.2022.0045
Vancouver	CAKALOGLU Y Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye. Hepatology forum. 2023; 4(1): 40 - 46. 10.14744/hf.2022.2022.0045
IEEE	CAKALOGLU Y "Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye." Hepatology forum, 4, ss.40 - 46, 2023. 10.14744/hf.2022.2022.0045
ISNAD	CAKALOGLU, YILMAZ. "Alcohol-related medicosocial problems and liver disorders: Burden of alcoholic cirrhosis and hepatocellular carcinoma in Turkiye". Hepatology forum 4/1 (2023), 40-46. https://doi.org/10.14744/hf.2022.2022.0045